Latest Breaking News On - Jie wei - Page 5 : vimarsana.com
These are the best bankers in real estate in Hong Kong
efinancialcareers.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efinancialcareers.com Daily Mail and Mail on Sunday newspapers.
This article is a collaboration between MedPage Today and:
Changes in gut microbiomes have been shown to be associated with an increased prevalence of symptomatic hand osteoarthritis (SHOA).
Among 1,388 participants included in a study published in
Arthritis & Rheumatology (women: 57.4%; mean age: 61.3 years; SHOA prevalence: 5.2%), researchers found higher levels of the bacteria
Bilophila and
Roseburia, in people with SHOA.
Jie Wei, PhD, a researcher with the Health Management Center at Xiangya Hospital and Central South University in China, served as the study s first author. The following excerpts from that study have been edited for length and clarity.
What did the study hypothesize regarding the gut microbiomes of people with hand OA?
Many garment factories are still unable to reopen
Cambodia s latest Covid-19 lockdown restrictions were eased last week – but many of the capital s garment factories are still dealing with impacts after a third wave of the virus surged through dozens of factories.
The Phnom Penh city municipality on Wednesday night (5 May) reduced the number of areas under strictest red zone lockdown measures to a few patches on the map, where factories are unable to open.
This includes parts of Choam Chao I commune (city district), Toul Sangke I commune, and neighbourhoods just outside the city in Kandal province s Bek Chan commune.
Jie Wei Said Leaving HSBC for Goldman Sachs in Hong Kong
mingtiandi.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mingtiandi.com Daily Mail and Mail on Sunday newspapers.
Date Time
Anticancer drug may improve outcome for severe COVID-19 patients
Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet in Sweden between February and April 2020. On average, blood oxygen levels, body temperature and inflammatory markers significantly improved in patients treated with a single dose of bevacizumab in addition to standard care. The research is published in Nature Communications.
Yihai Cao, photo: Ulf Sirborn
“To reduce COVID-19 mortality, we aim to develop an effective therapeutic paradigm for treating patients with severe COVID-19,” says corresponding author Yihai Cao, professor of vascular biology at the Department of Microbiology, Tumor and Cell Biology at Karolinska Institutet. “Our findings suggest that bevacizumab plus standard care is highly beneficial for patients with severe
vimarsana © 2020. All Rights Reserved.